Jain Global’s Perspective Therapeutics CATX Stock Holding History

Jain Global’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-14,100	Closed	-$45K	–	1095
2024 Q4	$45K	Buy	+14,100	New	+$115K	﹤0.01%	713

Other funds holding CATX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

NWMG

Nicholson Wealth Management Group Charlestown, South Carolina $170M AUM 10.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jain Global's CATX Position: Q1 2025 in Review

Jain Global sold out of Perspective Therapeutics (CATX) in Q1 2025, closing a stake of 14,100 shares — an estimated $45K sold.

Jain Global first reported a position in CATX in Q4 2024 and held it in 1 quarter. The position peaked at $45K in Q4 2024. 112 funds tracked by Wall St. Rank hold CATX as of Q1 2025.

Jain Global reported no remaining Perspective Therapeutics position as of Q1 2025 after selling out during the quarter.
Jain Global sold 14,100 Perspective Therapeutics shares in Q1 2025, an estimated $45K.
Jain Global first reported a position in Perspective Therapeutics in Q4 2024 and held it in 1 quarter.
Jain Global's Perspective Therapeutics position peaked at $45K in Q4 2024.
112 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q1 2025.

Based on Jain Global's 13F filing for Q1 2025, filed 15 May 2025.